MELISSA SáNCHEZ-RODRíGUEZ1,2, ROBERTO LAZZARINI-LECHUGA3, VERóNICA SOUZA-ARROYO1,4, LETICIA BUCIO-ORTIZ1,4, ROXANA U. MIRANDA-LABRA1,4, MONSERRAT GERARDO-RAMíREZ1, ARACELI PáEZ-ARENAS5, MOISES VERGARA-MENDOZA6, MARíA CONCEPCIóN GUTIéRREZ-RUIZ1,4, ALEJANDRO ESCOBEDO-CALVARIO1,2,*, LUIS E. GOMEZ-QUIROZ1,4,*
Oncology Research, Vol.33, No.8, pp. 2075-2084, 2025, DOI:10.32604/or.2025.064899
- 18 July 2025
Abstract Background: Growth differentiation factor 11 (GDF11), a transforming growth factor-beta superfamily member, is a crucial protein involved in many differentiation processes in embryogenesis and morphogenesis, and it has been extensively characterized due to its capacity to target poorly differentiated cells, including transformed or cancer cells. Aim: In the present work, we aimed to describe the effects on migration, proliferation, and metabolism in the T-cell acute lymphoblastic leukemia-derived cell line Jurkat. Methods: Based on previous evidence, we analyzed metabolic changes exerted by GDF11 and its relationship with the aggressive phenotype. Results: We found a profound impact on More >